Our results are in good agreement with a previous study that observed a marked upregulation of genes associated with cancer stem cells, such as Oct4, Sox2, Nanog, BMP2, and ALDH1, in prostate enzalutamide-resistant cells [33]. This evidence concerns the gene SOX2 and cancer.